Clinical Trials Logo

Clinical Trial Summary

This study aims to assess the efficacy of a zinc oxide eugenol sealer containing Enoxolone, a non-steroidal anti inflammatory drug (NSAID) on the pain relief after endodontic treatment.

The study design is a multicenter, doubled blinded randomized controlled trial. The comparator is the equivalent zinc oxide eugenol sealer without NSAID (allocation ratio is 1:1). The conventional endodontic treatment, using gutta percha and sealer, is done. Patients assess their pain for 7 days after permanent root obturation.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03874949
Study type Interventional
Source ACTEON Group
Contact
Status Completed
Phase N/A
Start date April 2, 2019
Completion date August 20, 2019

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04757753 - Root Canal Obturation With a Ready-to-use Root Canal Sealer (PA1704) Versus BioRootâ„¢ RCS: a Randomized Controlled Trial N/A
Completed NCT04935736 - Postoperative Pain After Root Canal Obturation With Sealer Containing Prednisolone. N/A
Completed NCT04885686 - Endodontic Post-operative Pain Evaluation of Patients After Using Endomethasone N or Endomethasone SP (EndoPOP) N/A
Completed NCT01728532 - Open, Multicentric Trial Evaluating the Efficacy and the Clinical Tolerance of PA0903 as Root Canal Sealer N/A
Completed NCT04753138 - Outcome of SBO With Calcium Silicate Sealer vs WVC With Resin Based Sealer N/A
Recruiting NCT05247138 - Measurement of the Clinical and Radiological Performance Impact of the Root Canal Treatment With BioRootTM RCS.
Completed NCT03732170 - Root Canal Treatment With TotalFill® Bioceramic Sealer and AH Plus® Sealer N/A